Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 14/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 11/20 | 0.73 |
| ▸ | GAA | P10253 | 7/20 | 0.73 |
| ▸ | GLA | P06280 | 6/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.73 |
| ▸ | HPGD | P15428 | 6/20 | 0.62 |
| ▸ | MAPT | P10636 | 4/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.51 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | AR | P10275 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | CASP3 | P42574 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.49 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.49 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.49 |
| ▸ | F2 | P00734 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1095445 | 1.00 | ALDH1A1 (0.73) | ALDH1A1KDM4EGAAGLAKMT2A | |
| SCHEMBL13171966 | 1.00 | ALDH1A1 (0.73) | ALDH1A1KDM4EGAAGLAKMT2A | |
| SCHEMBL381035 | 0.94 | ALDH1A1 (0.84) | ALDH1A1KDM4EGAAGLAKMT2A | |
| SCHEMBL1095310 | 0.94 | ALDH1A1 (0.84) | ALDH1A1KDM4EGAAGLAKMT2A | |
| SCHEMBL28985589 | 0.94 | ALDH1A1 (0.84) | ALDH1A1KDM4EGAAGLAKMT2A | |
| SCHEMBL381723 | 0.94 | ALDH1A1 (0.84) | ALDH1A1KDM4EGAAGLAKMT2A | |
| SCHEMBL336958 | 0.94 | ALDH1A1 (0.84) | ALDH1A1KDM4EGAAGLAKMT2A | |
| SCHEMBL3219473 | 0.94 | ALDH1A1 (0.84) | ALDH1A1KDM4EGAAGLAKMT2A | |
| SCHEMBL29466589 | 0.94 | ALDH1A1 (0.84) | ALDH1A1KDM4EGAAGLAKMT2A | |
| SCHEMBL28590565 | 0.92 | ALDH1A1 (0.86) | ALDH1A1KDM4EGAAGLAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 646 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12638448-B2 | Compositions, methods, and kits for detection of lipolytic activity | LONZA LTD (CH) | 2026-05-26 | — | — | US | claimed |
| EP-4028542-B1 | COMPOSITIONS, METHODS, AND KITS FOR DETECTION OF LIPOLYTIC ACTIVITY | LONZA AG (CH) | 2025-01-15 | — | — | EP | claimed |
| CN-116106281-A | Method for detecting lipase activity of intestinal bacteria in fecal sample | 大连医科大学 | 2023-05-12 | — | — | CN | claimed |
| EP-4028542-A1 | COMPOSITIONS, METHODS, AND KITS FOR DETECTION OF LIPOLYTIC ACTIVITY | Lonza Ltd. (CH) | 2022-07-20 | — | — | EP | claimed |
| CN-114364808-A | Compositions, methods and kits for detecting lipolytic activity | 隆萨有限公司 | 2022-04-15 | — | — | CN | claimed |
| US-20210096130-A1 | COMPOSITIONS, METHODS, AND KITS FOR DETECTION OF LIPOLYTIC ACTIVITY | LONZA LTD (CH) | 2021-04-01 | — | — | US | claimed |
| WO-2021050585-A1 | COMPOSITIONS, METHODS, AND KITS FOR DETECTION OF LIPOLYTIC ACTIVITY | LONZA LTD (CH) | 2021-03-18 | — | — | WO | claimed |
| EP-3384019-B1 | METHODS FOR PRODUCING LIPASES | NOVOZYMES AS (DK) | 2020-06-24 | — | — | EP | claimed |
| EP-3206723-A1 | BIOLOGICAL INDICATOR | American Sterilizer Company (US) | 2017-08-23 | — | — | EP | claimed |
| US-9701968-B2 | Biological indicator | AMERICAN STERILIZER COMPANY (US) | 2017-07-11 | — | — | US | claimed |
| US-20090117603-A1 | STERILIZATION INDICATOR | FRANCISKOVICH PHILLIP P | 2009-05-07 | — | — | US | claimed |
| WO-2008082728-A2 | STERILIZATION INDICATOR | AMERICAN STERILIZER COMPANY (US) | 2008-07-10 | — | — | WO | claimed |
| WO-2008079469-A2 | GENETICALLY ENGINEERED BIOLOGICAL INDICATOR | AMERICAN STERILIZER COMPANY (US) | 2008-07-03 | — | — | WO | claimed |
| US-20080070231-A1 | Reporter genes taken up by microorganism, and repressor gene inhibits expression | AMERICAN STERILIZER COMPANY | 2008-03-20 | — | — | US | claimed |
| US-20080070272-A1 | STERILIZATION INDICATOR | AMERICAN STERILIZER COMPANY | 2008-03-20 | — | — | US | claimed |
| US-7288400-B2 | Nucleic acids encoding esterases and methods of making and using them | VERENIUM CORPORATION (US) | 2007-10-30 | — | — | US | claimed |
| US-5094944-A | Umbelliferyl containing substrates | HAYES KENNETH R (US) | 1992-03-10 | — | — | US | claimed |
| WO-1990012886-A1 | FLUORESCENT AQUATIC BIOASSAY AND PROCEDURE | HAYES KENNETH R (US) | 1990-11-01 | — | — | WO | claimed |
| US-4868110-A | Methods and device for detection of microorganisms | BIOCONTROL SYSTEMS, INC. (US) | 1989-09-19 | — | — | US | claimed |
| EP-0264221-A2 | Methods and device for detection of microorganisms | BioControl Systems, Inc. (US) | 1988-04-20 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12638448-B2 | Compositions, methods, and kits for detection of lipolytic activity | LPL, LIPA, LIPC | ALDH1A1 3234/4885KDM4E 1672/4885GAA 696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.